Identification of a novel mitochondrial protein (“mitoNEET”) cross-linked specifically by a thiazolidinedione photoprobe (Q28211498)

DOI

https://api.crossref.org/works/10.1152/AJPENDO.00424.2003

23 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00424.2003

23 March 2024

Jerry R. Colca

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14570702

23 March 2024

William G. McDonald

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14570702

23 March 2024

Daniel J. Waldon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14570702

23 March 2024

Joseph W. Leone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14570702

23 March 2024

June M. Lull

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14570702

23 March 2024

Carol A. Bannow

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14570702

23 March 2024

Eric T. Lund

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14570702

23 March 2024

W. Rodney Mathews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14570702

23 March 2024

language of work or name

English

0 references

publication date

February 2004

0 references

21 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14570702

full work available at URL

23 March 2024

https://www.physiology.org/doi/pdf/10.1152/ajpendo.00424.2003

1 reference

DOI

https://api.crossref.org/works/10.1152/AJPENDO.00424.2003

American Journal of Physiology - Endocrinology and Metabolism

23 March 2024

published in

0 references

volume

286

0 references

issue

0 references

page(s)

E252-60

0 references

cites work

Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Troglitazone action is independent of adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Ciglitazone, a New Hypoglycemic Agent: I. Studies in ob/ob and db/db Mice, Diabetic Chinese Hamsters, and Normal and Streptozotocin-Diabetic Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Cross-linking in the Living Cell Locates the Site of Action of Oxazolidinone Antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

The mitochondrial trifunctional protein: centre of a beta-oxidation metabolon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Thiazolidinediones: metabolic actions in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Reduction of Insulin Resistance in Obese and/or Diabetic Animals by 5-[4-(1-Methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, Ciglitazone), a New Antidiabetic Agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Comparison of effects of thiazolidinediones on cardiovascular risk factors: observations from a clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

A futile metabolic cycle activated in adipocytes by antidiabetic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Preadipocyte differentiation in vitro: identification of a highly active adipogenic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

New oral thiazolidinedione antidiabetic agents act as insulin sensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Prohibitin, an antiproliferative protein, is localized to mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Expression and characterization of recombinant rat Acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Differences in lipid profiles of patients given rosiglitazone followed by pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

PPAR gamma and the treatment of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Pioglitazone promotes insulin-induced activation of phosphoinositide 3-kinase in 3T3-L1 adipocytes by inhibiting a negative control mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Crystal structure of the ligand binding domain of the human nuclear receptor PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00424.2003

Studies on the euglycemic and hypolipidemic potentials of the novel indole analogue of thiazolidinedione, DRF 2189.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00424.2003

Pioglitazone hydrochloride inhibits cholesterol absorption and lowers plasma cholesterol concentrations in cholesterol-fed rats

23 March 2024

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00424.2003

Muscle long-chain acyl CoA esters and insulin resistance

23 March 2024

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00424.2003

Effect of the peroxisome proliferator-activated receptor-gamma 2 pro(12)ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds

23 March 2024

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00424.2003

Malonyl-CoA, fuel sensing, and insulin resistance

23 March 2024

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00424.2003

Lipid abnormalities in tissues of the KKAy mouse: effects of pioglitazone on malonyl-CoA and diacylglycerol

23 March 2024

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00424.2003

23 March 2024

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017